Results 291 to 300 of about 3,248,558 (306)

Lung cancer: New biological insights and recent therapeutic advances

Ca-A Cancer Journal for Clinicians, 2011
Suresh S Ramalingam, Fadlo R Khuri
exaly  

Translating cancer genomes and transcriptomes for precision oncology

Ca-A Cancer Journal for Clinicians, 2016
Sameek Roychowdhury, Arul M Chinnaiyan
exaly  

Advances in Understanding and Management of Myeloproliferative Neoplasms

Ca-A Cancer Journal for Clinicians, 2009
Paola Guglielmelli
exaly  

Missed therapeutic and prevention opportunities in women with BRCA‐mutated epithelial ovarian cancer and their families due to low referral rates for genetic counseling and BRCA testing: A review of the literature

Ca-A Cancer Journal for Clinicians, 2017
Paul J Hoskins, Walter H Gotlieb
exaly  

ESR1 mutations—a mechanism for acquired endocrine resistance in breast cancer

Nature Reviews Clinical Oncology, 2015
Rinath M Jeselsohn, Gilles Buchwalter, Carmine De Angelis   +2 more
exaly  

The influence of subclonal resistance mutations on targeted cancer therapy

Nature Reviews Clinical Oncology, 2015
Lawrence A Loeb, Jesse J Salk
exaly  

Population genetic testing for cancer susceptibility: founder mutations to genomes

Nature Reviews Clinical Oncology, 2015
William D Foulkes, Clare Turnbull
exaly  

Mutations of the BRAF gene in human cancer

Nature, 2002
Jon Teague, Kristian Gray, Jamie Hughes
exaly  

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

Nature, 2009
Robert M Prins, Patrick S Ward, Linda M Liau   +2 more
exaly  

Rates of testing forBRCAmutations in young women are on the rise

Ca-A Cancer Journal for Clinicians, 2016
exaly